Who makes Drug: PF-07923568?

Drug: PF-07923568 is developed by Pfizer.

What development phase is Drug: PF-07923568 in?

Drug: PF-07923568 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Drug: PF-07923568

Pfizer · Phase 1 active Small molecule

At a glance

Generic name	Drug: PF-07923568
Also known as	Sisunatovir
Sponsor	Pfizer
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Drug: PF-07923568 CI brief — competitive landscape report
Drug: PF-07923568 updates RSS · CI watch RSS
Pfizer portfolio CI